253 related articles for article (PubMed ID: 35812370)
1. Peptidome Surveillance Across Evolving SARS-CoV-2 Lineages Reveals HLA Binding Conservation in Nucleocapsid Among Variants With Most Potential for T-Cell Epitope Loss in Spike.
Wnuk K; Sudol J; Spilman P; Soon-Shiong P
Front Immunol; 2022; 13():918928. PubMed ID: 35812370
[TBL] [Abstract][Full Text] [Related]
2. In silico analysis of mutant epitopes in new SARS-CoV-2 lineages suggest global enhanced CD8+ T cell reactivity and also signs of immune response escape.
Pretti MAM; Galvani RG; Scherer NM; Farias AS; Boroni M
Infect Genet Evol; 2022 Apr; 99():105236. PubMed ID: 35149224
[TBL] [Abstract][Full Text] [Related]
3. CD8
Qiu C; Xiao C; Wang Z; Zhu G; Mao L; Chen X; Gao L; Deng J; Su J; Su H; Fang EF; Zhang ZJ; Zhang J; Xie C; Yuan J; Luo OJ; Huang LA; Wang P; Chen G
Front Immunol; 2021; 12():764949. PubMed ID: 35116022
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 coronavirus vaccine T cell epitope prediction analysis based on distributions of HLA class I loci (HLA-A, -B, -C) across global populations.
Cun Y; Li C; Shi L; Sun M; Dai S; Sun L; Shi L; Yao Y
Hum Vaccin Immunother; 2021 Apr; 17(4):1097-1108. PubMed ID: 33175614
[TBL] [Abstract][Full Text] [Related]
5. Minimal Crossover between Mutations Associated with Omicron Variant of SARS-CoV-2 and CD8
Redd AD; Nardin A; Kared H; Bloch EM; Abel B; Pekosz A; Laeyendecker O; Fehlings M; Quinn TC; Tobian AAR
mBio; 2022 Apr; 13(2):e0361721. PubMed ID: 35229637
[TBL] [Abstract][Full Text] [Related]
6. In Silico Genome Analysis Reveals the Evolution and Potential Impact of SARS-CoV-2 Omicron Structural Changes on Host Immune Evasion and Antiviral Therapeutics.
Chauhan D; Chakravarty N; Jeyachandran AV; Jayakarunakaran A; Sinha S; Mishra R; Arumugaswami V; Ramaiah A
Viruses; 2022 Nov; 14(11):. PubMed ID: 36366559
[TBL] [Abstract][Full Text] [Related]
7. A bioinformatic analysis of T-cell epitope diversity in SARS-CoV-2 variants: association with COVID-19 clinical severity in the United States population.
Kim GJ; Elnaggar JH; Varnado M; Feehan AK; Tauzier D; Rose R; Lamers SL; Sevalia M; Nicholas N; Gravois E; Fort D; Crabtree JS; Miele L
Front Immunol; 2024; 15():1357731. PubMed ID: 38784379
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.
Garrett ME; Galloway JG; Wolf C; Logue JK; Franko N; Chu HY; Matsen FA; Overbaugh JM
Elife; 2022 Jan; 11():. PubMed ID: 35072628
[TBL] [Abstract][Full Text] [Related]
9. Limited Recognition of Highly Conserved Regions of SARS-CoV-2.
Swaminathan S; Lineburg KE; Ambalathingal GR; Crooks P; Grant EJ; Mohan SV; Raju J; Panikkar A; Le Texier L; Tong ZWM; Chew KY; Neller MA; Short KR; Gowda H; Gras S; Khanna R; Smith C
Microbiol Spectr; 2022 Feb; 10(1):e0278021. PubMed ID: 35196796
[TBL] [Abstract][Full Text] [Related]
10. Mutations in spike protein T cell epitopes of SARS-COV-2 variants: Plausible influence on vaccine efficacy.
Sankaranarayanan S; Mohkhedkar M; Janakiraman V
Biochim Biophys Acta Mol Basis Dis; 2022 Sep; 1868(9):166432. PubMed ID: 35568352
[TBL] [Abstract][Full Text] [Related]
11. Artificial intelligence predicts the immunogenic landscape of SARS-CoV-2 leading to universal blueprints for vaccine designs.
Malone B; Simovski B; Moliné C; Cheng J; Gheorghe M; Fontenelle H; Vardaxis I; Tennøe S; Malmberg JA; Stratford R; Clancy T
Sci Rep; 2020 Dec; 10(1):22375. PubMed ID: 33361777
[TBL] [Abstract][Full Text] [Related]
12. A novel vaccine based on SARS-CoV-2 CD4
Palatnik-de-Sousa I; Wallace ZS; Cavalcante SC; Ribeiro MPF; Silva JABM; Cavalcante RC; Scheuermann RH; Palatnik-de-Sousa CB
Sci Rep; 2022 Oct; 12(1):16731. PubMed ID: 36202985
[TBL] [Abstract][Full Text] [Related]
13. Evolution of SARS-CoV-2-specific CD4
Brand M; Keşmir C
Immunogenetics; 2023 Jun; 75(3):283-293. PubMed ID: 36719467
[TBL] [Abstract][Full Text] [Related]
14. Degenerate CD8 Epitopes Mapping to Structurally Constrained Regions of the Spike Protein: A T Cell-Based Way-Out From the SARS-CoV-2 Variants Storm.
Boni C; Cavazzini D; Bolchi A; Rossi M; Vecchi A; Tiezzi C; Barili V; Fisicaro P; Ferrari C; Ottonello S
Front Immunol; 2021; 12():730051. PubMed ID: 34566990
[TBL] [Abstract][Full Text] [Related]
15. Bioinformatics analysis of epitope-based vaccine design against the novel SARS-CoV-2.
Chen HZ; Tang LL; Yu XL; Zhou J; Chang YF; Wu X
Infect Dis Poverty; 2020 Jul; 9(1):88. PubMed ID: 32741372
[TBL] [Abstract][Full Text] [Related]
16. Dominant CD8
Taus E; Hofmann C; Ibarrondo FJ; Hausner MA; Fulcher JA; Krogstad P; Ferbas KG; Tobin NH; Rimoin AW; Aldrovandi GM; Yang OO
Front Immunol; 2022; 13():835830. PubMed ID: 35273611
[TBL] [Abstract][Full Text] [Related]
17.
Isaeva OI; Ketelaars SLC; Kvistborg P
Front Immunol; 2022; 13():891524. PubMed ID: 35572563
[TBL] [Abstract][Full Text] [Related]
18. Breadth and Durability of SARS-CoV-2-Specific T Cell Responses following Long-Term Recovery from COVID-19.
Dang TTT; Anzurez A; Nakayama-Hosoya K; Miki S; Yamashita K; de Souza M; Matano T; Kawana-Tachikawa A
Microbiol Spectr; 2023 Aug; 11(4):e0214323. PubMed ID: 37428088
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2-specific T-cell epitope repertoire in convalescent and mRNA-vaccinated individuals.
Lang-Meli J; Luxenburger H; Wild K; Karl V; Oberhardt V; Salimi Alizei E; Graeser A; Reinscheid M; Roehlen N; Reeg DB; Giese S; Ciminski K; Götz V; August D; Rieg S; Waller CF; Wengenmayer T; Staudacher D; Huzly D; Bengsch B; Kochs G; Schwemmle M; Emmerich F; Boettler T; Thimme R; Hofmann M; Neumann-Haefelin C
Nat Microbiol; 2022 May; 7(5):675-679. PubMed ID: 35484232
[TBL] [Abstract][Full Text] [Related]
20. Identification of a promiscuous conserved CTL epitope within the SARS-CoV-2 spike protein.
Jiang S; Wu S; Zhao G; He Y; Guo X; Zhang Z; Hou J; Ding Y; Cheng A; Wang B
Emerg Microbes Infect; 2022 Dec; 11(1):730-740. PubMed ID: 35171086
[No Abstract] [Full Text] [Related]
[Next] [New Search]
